Gleason grading and prognostic factors in carcinoma of the prostate (Q29306305)

9 April 2017

Peter A Humphrey

1 reference

9 April 2017

publication date

13 February 2004

1 reference

9 April 2017

1 reference

9 April 2017

volume

1 reference

9 April 2017

issue

1 reference

9 April 2017

page(s)

292-306

1 reference

Histologic grading of prostate cancer: a retrospective and prospective overview

9 April 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800054

7 January 2021

The histology and prognosis of prostatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800054

7 January 2021

Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800054

7 January 2021

Histologic grading of prostate cancer: a perspective

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800054

7 January 2021

Heterogeneity of prostate cancer in radical prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800054

7 January 2021

Evaluation of histological grading (Gleason) in carcinoma of the prostate: adverse influence of highest grade

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800054

7 January 2021

Histological grade heterogeneity in multifocal prostate cancer. Biological and clinical implications

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800054

7 January 2021

The prognostic significance of tertiary Gleason patterns of higher grade in radical prostatectomy specimens: a proposal to modify the Gleason grading system

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800054

7 January 2021

Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800054

7 January 2021

Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800054

7 January 2021

Gleason score 2-4 adenocarcinoma of the prostate on needle biopsy: a diagnosis that should not be made

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800054

7 January 2021

Intraglandular tumor extent and prognosis in prostatic carcinoma: application of a grid method to prostatectomy specimens.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800054

7 January 2021

Prospective characterization of pathological features of prostatic carcinomas detected via serum prostate specific antigen based screening

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800054

7 January 2021

Cribriform carcinoma of the prostate and cribriform prostatic intraepithelial neoplasia: incidence and clinical implications

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800054

7 January 2021

Spread of adenocarcinoma within prostatic ducts and acini. Morphologic and clinical correlations

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800054

7 January 2021

Pseudohyperplastic prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800054

7 January 2021

Pseudohyperplastic prostatic adenocarcinoma on needle biopsy and simple prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800054

7 January 2021

Correlation of prostate needle biopsy and radical prostatectomy Gleason grade in academic and community settings

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800054

7 January 2021

Interobserver reproducibility of Gleason grading of prostatic carcinoma: urologic pathologists.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800054

7 January 2021

Interobserver reproducibility of Gleason grading of prostatic carcinoma: general pathologist.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800054

7 January 2021

Reproducibility of Gleason grading of prostate cancer can be improved by the use of reference images.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800054

7 January 2021

Assessment of prostate carcinoma in core needle biopsy--definition of minimal criteria for the diagnosis of cancer in biopsy material

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800054

7 January 2021

Prognostic value of the Gleason score in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800054

7 January 2021

The relative importance of anatomic and PSA factors to outcomes after radical prostatectomy for prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800054

7 January 2021

Biological determinants of cancer progression in men with prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800054

7 January 2021

Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800054

7 January 2021

Making the most out of six systematic sextant biopsies

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800054

7 January 2021

Predictors of Gleason pattern 4/5 prostate cancer on prostatectomy specimens: can high grade tumor be predicted preoperatively?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800054

7 January 2021

Quantitative Light Microscopy in Urological Oncology

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800054

7 January 2021

Gene expression correlates of clinical prostate cancer behavior

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800054

7 January 2021

Delineation of prognostic biomarkers in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800054

7 January 2021

Should each core with prostate cancer be assigned a separate gleason score?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800054

7 January 2021

Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800054

7 January 2021

Carcinoma extent in prostate needle biopsy tissue in the prediction of whole gland tumor volume in a screening population

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800054

7 January 2021

Multiple measures of carcinoma extent versus perineural invasion in prostate needle biopsy tissue in prediction of pathologic stage in a screening population

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800054

7 January 2021

Recommendations for the reporting of resected prostate carcinomas. Association of Directors of Anatomic and Surgical Pathology

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800054

7 January 2021

Morphologic and molecular prognostic markers in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800054

7 January 2021

10.1038/MODPATHOL.3800054

Identifiers

DOI

2 references

9 April 2017

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

1027726502

0 references

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

14976540

1 reference

Consolidated OpenCitations Corpus – April 2017